GlassScriptPhysician profile
Kathryn A Schulz
NPI 1336178961
$582.88
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $255 · 2022: $214 · 2023: $86.18 · 2024: $27.57.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $114.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $113.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanir Pharmaceuticals, INC. | $72.21 | 2021-2022 | |
| Organogenesis INC. | $63.14 | 2022 | |
| Abbvie INC. | $59.50 | 2021-2024 | |
| Acadia Pharmaceuticals INC | $58.53 | 2021 | |
| Biogen, INC. | $57.74 | 2021-2022 | |
| Mdd US Operations, LLC | $40.06 | 2022-2023 | Gocovri |
| Csl Behring | $39.64 | 2022-2023 | Hizentra |
| Lilly USA, LLC | $29.69 | 2021-2022 | |
| Si-Bone, INC. | $28.16 | 2021 | |
| Tanabe Pharma America, INC. | $21.09 | 2022 | |
| Supernus Pharmaceuticals, INC. | $21.05 | 2022 | |
| Livanova USA, INC. | $20.50 | 2023 | Vns Therapy Sentiva Model 1000 Generator |
| Kci USA, INC. | $20.39 | 2021 | |
| Ucb, INC. | $20.02 | 2023 | Briviact |
| Stryker Corporation | $15.84 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $15.32 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathryn Schulz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.